Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment.

[1]  Faiza Fakhfakh,et al.  In silico investigation of the impact of synonymous variants in ABCB4 gene on mRNA stability/structure, splicing accuracy and codon usage: Potential contribution to PFIC3 disease , 2016, Comput. Biol. Chem..

[2]  Yongwook Choi,et al.  PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels , 2015, Bioinform..

[3]  W. Seeger,et al.  ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth , 2014, Scientific Reports.

[4]  P. Jara,et al.  Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity , 2014, Gut.

[5]  M. Rastaldi,et al.  Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction , 2013, European Journal of Human Genetics.

[6]  O. Rosmorduc,et al.  Hepatobiliary anomalies associated with ABCB4/MDR3 deficiency in adults: a pictorial essay , 2013, Insights into Imaging.

[7]  Joaquín Dopazo,et al.  SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants , 2011, Nucleic Acids Res..

[8]  P. Hou,et al.  Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter , 2011, Thyroid research.

[9]  F. Callea,et al.  Two novel mutations in African and Asian children with progressive familial intrahepatic cholestasis type 3. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[10]  D. Consonni,et al.  Clinical Features and Genotype-Phenotype Correlations in Children With Progressive Familial Intrahepatic Cholestasis Type 3 Related to ABCB4 Mutations , 2011, Journal of pediatric gastroenterology and nutrition.

[11]  Tal Pupko,et al.  ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids , 2010, Nucleic Acids Res..

[12]  E. Jacquemin,et al.  The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. , 2010, Seminars in liver disease.

[13]  R. Kim,et al.  Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability , 2010, Pharmacogenetics and genomics.

[14]  Predrag Radivojac,et al.  Automated inference of molecular mechanisms of disease from amino acid substitutions , 2009, Bioinform..

[15]  Richard J. Thompson,et al.  Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre‐messenger RNA splicing , 2009, Hepatology.

[16]  S. Shin,et al.  Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease , 2008, The British journal of surgery.

[17]  P. Jones,et al.  Polymorphisms in ABCG5/G8 transporters linked to hypercholesterolemia and gallstone disease. , 2008, Nutrition reviews.

[18]  I. Kerr,et al.  Structure-based interpretation of the mutagenesis database for the nucleotide binding domains of P-glycoprotein. , 2008, Biochimica et biophysica acta.

[19]  R. Sokol,et al.  The multiple facets of ABCB4 (MDR3) deficiency , 2007, Current treatment options in gastroenterology.

[20]  M. Seia,et al.  Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3) , 2007, European Journal of Human Genetics.

[21]  Michael Krawczak,et al.  A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease , 2007, Nature Genetics.

[22]  M. Trauner,et al.  MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. , 2007, Seminars in liver disease.

[23]  C. Paulusma,et al.  Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein) , 2007, Pflügers Archiv - European Journal of Physiology.

[24]  Emidio Capriotti,et al.  Bioinformatics Original Paper Predicting the Insurgence of Human Genetic Diseases Associated to Single Point Protein Mutations with Support Vector Machines and Evolutionary Information , 2022 .

[25]  E. Sokal,et al.  Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy. , 2004, Acta gastro-enterologica Belgica.

[26]  U. Beuers,et al.  Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited , 2002, Hepatology.

[27]  E. Jacquemin.  Role of Multidrug Resistance 3 Deficiency in Pediatric and Adult Liver Disease: One Gene for Three Diseases , 2001, Seminars in liver disease.

[28]  P. Bosma,et al.  The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. , 2001, Gastroenterology.

[29]  P. Bosma,et al.  Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Groen,et al.  The role of mdr2 P‐glycoprotein in hepatobiliary lipid transport , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  J. Deleuze,et al.  Defect of multidrug‐resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis , 1996, Hepatology.

[32]  H. Lewin,et al.  A simple method for DNA extraction from leukocytes for use in PCR. , 1992, BioTechniques.

[33]  H. Kaback,et al.  Role of proline residues in the structure and function of a membrane transport protein. , 1991, Biochemistry.

[34]  Jianzhu Ma,et al.  RaptorX server: a resource for template-based protein structure modeling. , 2014, Methods in molecular biology.

[35]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.